Ron Andrews, CEO of Clarient talks about the launch of GE’s cancer patient advocacy campaign and how molecular pathology advances are being used to develop new cancer treatments.
Archive
CONNECT WITH US
BROWSE BY TAGS
#epatcon advertising branding business communication Communities community Compliance conference Conferences data Design digital strategy Digital Tools Education engagement events Facebook FDA Health Health care healthcare information innovation Legal Issues marketing media mobile online patient Patients Pharma Pharmaceutical industry Pixels and Pills research social media Social network strategy technology Thought Leaders Trends Twitter User Experience user needs Video